Daraxonrasib (RMC-6236) IC50 for Cell-based and Cell-free Assays

Jump to:

• Daraxonrasib (RMC-6236) Mechanism of Action: RAS Inhibition in Pancreatic Cancer Cell Research
• Selectivity & Specificity
• Daraxonrasib (RMC-6236) Working Concentration | Cell Culture | Treatment
• Daraxonrasib (RMC-6236) Solubility in DMSO
• Daraxonrasib (RMC-6236) Storage & Stability
• Daraxonrasib (RMC-6236) Combination Database
• Daraxonrasib (RMC-6236) Molecular Weight | Chemical Structure | Stock Solution
• Daraxonrasib (RMC-6236) Sigma (SML4213)? Try a better option.
• Daraxonrasib (RMC-6236) MCE (HY-148439)? Try a better option.
• Daraxonrasib (RMC-6236) Cayman (41982)? Try a better option.
• Daraxonrasib (RMC-6236) Abmole (M40832)? Try a better option.
• Daraxonrasib (RMC-6236) SDS｜MSDS
• Daraxonrasib (RMC-6236) in Pancreatic Ductal Adenocarcinoma (PDAC)
• Daraxonrasib (RMC-6236) in Non-Small Cell Lung Cancer (NSCLC)
• Daraxonrasib (RMC-6236) in Colorectal Cancer (CRC)